Update on COVID-19 and Lonza Supply
As the situation with the COVID-19 pandemic evolves, we will keep you informed about any potential supply disruptions which may occur as a result.
As the situation with the COVID-19 pandemic evolves, we will keep you informed about any potential supply disruptions which may occur as a result.
As the situation with the COVID-19 pandemic evolves, we will keep you informed about any potential supply disruptions which may occur as a result.
Get information about factors to consider when selecting cells to study COVID-19 transmission.
Get information about factors to consider when selecting cells to study COVID-19 transmission.
Lonza now offers multiple primary cell types including immune and lung cells with high resolution HLA characterization.
Lonza now offers multiple primary cell types including immune and lung cells with high resolution HLA characterization.
Partner with us for an integrated portfolio of products and services, helping you to accelerate the development of cell and gene therapies to bring new treatments to patients faster.
Partner with us for an integrated portfolio of products and services, helping you to accelerate the development of cell and gene therapies to bring new treatments to patients faster.
Discover our range of airway and immune cells, culture media for primary cells, media and endotoxin testing products for vaccine and protein production, or use our NucleofectorTM Technology for virus creation.
Discover our range of airway and immune cells, culture media for primary cells, media and endotoxin testing products for vaccine and protein production, or use our NucleofectorTM Technology for virus creation.
We provide life science researchers with the tools they need to develop and test therapeutics, from basic research to final product release. Lonza’s Bioscience products and services range from cell culture and discovery technologies for research, to quality control tests and software for biomanufacturing.